‘FOCUSING ON R&D EXPANSION’

“We look forward to bringing our expertise on Tuberculosis diagnosis to work on early detection of TB using serologybased testing. One of our main priorities also has been to look at better industry-academia collaboration founded on greater visibility into areas of research being pursued by many institutions. In the long term, we see ourselves as the drivers of innovations of diagnosis and be a contributor to the Make In India initiative. In terms of finance, our next funding requirement will be for our manufacturing facility and expansion of R&D and we will be on road for a Series A fundraise shortly. With a pipeline of products scheduled to come through our R& D and commercialisation, we expect to be cash flow positive in two years.” - SUSHIL MEHTA, Chairman, NextGen Invitro Diagnostics, Gurugram